Moreover, the TCGA dataset indicated that SMARCA5 expression in all four of the glioblastoma subtypes (classical, mesenchymal, neural, and proneural) was significantly higher than in normal controls (Figure 6E). The gene discussed is SMARCA5; the disease is glioblastoma.